Fact Sheets

FDA: Lung Illnesses Associated with Use of Vaping Products (Updated periodically)

FDA : FDA warns JUUL Labs for marketing unauthorized modified risk tobacco products, including in outreach to youth (9/9/2019)

CDC : Vaping Illnesses: Consumers can Help Protect Themselves by Avoiding Tetrahydrocannabinol (THC)-Containing Vaping Products (9/9/2019)

CDC Transcript : Telebriefing on Severe Pulmonary Disease Associated with Use of E-cigarettes (8/23/2019)

FDA Special Announcement : Some E-cigarette Users Are Having Seizures, Most Reports Involving Youth and Young Adults (4/3/2019)

CDC: E-Cigarettes Basic Information - Infographic and Fact Sheet

CDC: E-Cigarettes and Youth - Infographic and Fact Sheet

NIDA: DrugFacts: Electronic Cigarettes

Amer. Lung Assn: Myths and Facts About E-cigarettes

Amer. Lung Assn: E-cigarettes and Lung Health

Center on Addiction: E-Cigarettes Separate the myths from the facts

Journal Articles

Giant cell interstitial pneumonia secondary to cobalt exposure from e-cigarette use  (2019)

Life-threatening bronchiolitis related to electronic cigarette use in a Canadian youth (11/20/2019)

Clinical review | BMJ: What are the respiratory effects of e-cigarettes? (9/30/2019)

NJEM (collected articles): E-Cigarettes and Vaping-Related Disease

Electronic cigarettes disrupt lung lipid homeostasis and innate immunity independent of nicotine (9/4/2019)

Pulmonary Lipid-Laden Microphages and Vaping (9/6/2019)

Acute Effects of Electronic Cigarette Aerosol Inhalation on Vascular Function Detected at Quantitative MRI (8/2019)

Nicotine arms race: JUUL and the high-nicotine product market (1/31/2019)

Evaluation of Nicotine and the Components of e-Liquids Generated from e-Cigarette Aerosols (10/26/2018)

The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids (10/19/2018)

Formation of flavorant–propylene Glycol Adducts With Novel Toxicological Properties in Chemically Unstable E-Cigarette Liquids (10/18/2018)

The Blue Lotus Flower (Nymphea caerulea) Resin Used in a New Type of Electronic Cigarette, the ReBuildable Dripping Atomizer (3/7/2017)

Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes (8/29/2016)

Concentration of Nicotine and Glycols in 27 Electronic Cigarette Formulations (7/14/2016)

Analysis of a Commercial Marijuana e-Cigarette Formulation (4/7/2016)

Electronic cigarette power affects count concentration and particle size distribution of vaping aerosol (12/31/2018)

E-cigarettes—An unintended illicit drug delivery system

Association Between Electronic Cigarette Use and Myocardial Infarction

Identification of MDMB-FUBINACA in commercially available e-liquid formulations sold for use in electronic cigarettes (February 2017)

Analysis of a Commercial Marijuana e-Cigarette Formulation

Concentration of Nicotine and Glycols in 27 Electronic Cigarette Formulations

Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection (2010)

Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes

Ethanol concentration in 56 refillable electronic cigarettes liquid formulations determined by headspace gas chromatography with flame ionization detector (HS-GC-FID).

Other Resources

COVID-19 and Smoking/Vaping: A graphical 1-pager developed by the MassGeneral Hospital for Children

CDC/MMWR: Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019

CDC/MMWR: Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019

CDC/MMWR: Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — 10 States, August–October 2019

CDC/MMWR: Risk Factors for E-Cigarette, or Vaping, Product Use–Associated Lung Injury (EVALI) Among Adults Who Use E-Cigarette, or Vaping, Products — Illinois, July–October 2019

CDC/MMWR: Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, October 2019

CDC/MMWR: E-cigarette Use, or Vaping, Practices and Characteristics Among Persons with Associated Lung Injury — Utah, April–October 2019

CDC/MMWR: Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October 2019

FDA: Statement on consumer warning to stop using THC vaping products amid ongoing investigation into lung illnesses (10/4/2019)

CDC/MMWR: Severe Pulmonary Disease Associated with Electronic-Cigarette-Product Use -- Interim Guidance (9/13/2019)

CDC/MMWR: Outbreak of Electronic-Cigarette -- Associated Acute Lipoid Pneumonia -- North Carolina, July-August 2019 (9/13/2019)

FDA: Statement on federal and state collaboration to investigate respiratory illnesses reported after use of e-cigarette products (8/30/2019)

CDC Newsroom: CDC, FDA, States Continue to Investigate Severe Pulmonary Disease Among People Who Use E-cigarettes (Updated August 23, 2019)

NY Times: Ads Pitching CBD as a Cure-All Are Everywhere. Oversight Hasn’t Kept Up (8/13/2019) 

FDA News Release: FDA notifies four companies to remove 44 flavored e-liquid and hookah tobacco products from the market for not having required marketing authorization (August 8, 2019)

CDC/MMWR: Tobacco Product Use Among Middle and High School Students — United States, 2011–2018 (February 15, 2019)

NIDA/MTF: Survey Results Sending Smoke Signals That Teens Are Vaping at Increasing Rates (December 2018)

HHS: Researchers Explore Health Effects of E-Cigarettes

FDA press release: FDA takes new steps to address epidemic of youth e-cigarette use (September 2018)

NIDA: Electronic Cigarettes (E-cigarettes) general information (June 2018)

FDA: Vaporizers, E-Cigarettes, and other Electronic Nicotine Delivery Systems (ENDS)

FDA:  Regulations for E-Cigarettes, Cigars, and All Other Tobacco Products

NASEM press release: New Report One of the Most Comprehensive Studies on Health Effects of E-Cigarettes

• Study: Public Health Consequences of E-Cigarettes

HHS: Surgeon General's Website on E-cigarettes

Cancer.gov: Adolescents Who Wouldn’t Have Smoked May Be Drawn to E-Cigarettes